Skip to Content

Disclaimer

Disclaimer
MDS makes every effort to publish accurate information on the website. "Google Translate" is provided as a free tool for visitors to read content in one's native language. Translations are not guaranteed to be 100% accurate. Neither MDS nor its employees assume liability for erroneous translations of website content.

 

International Congress of Parkinson’s Disease and Movement Disorders ®

Congress

Plenary Session 2201

Aging and Comorbidities in Parkinsonism

Monday, October 5, 2026
8:00 - 9:30 | Grand Ballroom, Level 1

This session will focus on how clinicians can incorporate advances in aging research to better understand the pathogenesis of Parkinsonism, recognize differences in clinical presentation, and tailor treatment strategies, particularly to patients of advanced age.

Chairs:

Jee-Young Lee, Korea
Ron Postuma, Canada

Presenters:

Co-Pathology in Parkinson’s Disease – How Does it Affect the Outcome?
Shigeo Murayama, Japan

Understanding Frailty in Parkinsonism
Alison Yarnall, United Kingdom

Diagnosis and Treatment of Parkinsonism in Advanced Age

CSPC Liaison(s):

Ron Postuma, Canada

Learning Objectives

At the conclusion of this session, participants should be better able to:

  1. Recognize the common neuronal co-pathologies in Parkinson’s disease and their clinical implications
  2. Recognize frailty in parkinsonism, understand its pathophysiology and implications for treatment
  3. Incorporate age into making diagnosis and targeting clinical care for parkinsonism

Recommended Audience

Clinician / General Neurology
Fellow / Resident / Student
Health Professional (non-physician)
Industry
Researcher / Basic Science

Education Level

Advanced / Expert
Beginner / Foundational
Intermediate / Experienced